Thomas Graney
2017
In 2017, Thomas Graney earned a total compensation of $1.9M as SVP & Chief Financial Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $110,392 |
| Salary | $154,423 |
| Stock Awards | $1,500,140 |
| Other | $12,445 |
| Total | $1,927,400 |
Graney received $1.5M in stock awards, accounting for 78% of the total pay in 2017.
Graney also received $150K in bonus, $110.4K in non-equity incentive plan, $154.4K in salary and $12.4K in other compensation.
Rankings
In 2017, Thomas Graney's compensation ranked 5,686th out of 14,666 executives tracked by ExecPay. In other words, Graney earned more than 61.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,686 out of 14,666 | 61st |
Division Manufacturing | 2,063 out of 5,772 | 64th |
Major group Chemicals And Allied Products | 638 out of 2,075 | 69th |
Industry group Drugs | 492 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 387 out of 1,333 | 71st |
Source: SEC filing on April 17, 2018.
Graney's colleagues
We found six more compensation records of executives who worked with Thomas Graney at Vertex Pharmaceuticals in 2017.
2017
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2017
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2017
Ian Smith
Vertex Pharmaceuticals
Chief Operating Officer
2017
David Altshuler
Vertex Pharmaceuticals
Chief Scientific Officer
2017
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2017
Stuart Arbuckle
Vertex Pharmaceuticals